Scheda del titolo · trimestre archiviato
NVS
Novartis AG · Healthcare · Drug Manufacturers - General
20Holder monitorati
-1Δ titolari
49.48MQuote detenute
$6.35BValore dichiarato
+0Nuove posizioni
−1Uscite
Input di momentum (manager comparabili):
ampiezza dei detentori -4.8% ·
flusso azionario -7.9% ·
nuove posizioni nette -5.0%
— formula
Distribuzione diffusa — azioni in calo e minor numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q3 2025
Proprietà nel tempo
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 125 | +1 | 102.39M | $16.04B | +8 | −7 |
| Q1 2026 | 126 | +1 | 113.27M | $17.29B | +8 | −7 |
| Q4 2025 | 124 | +1 | 102.45M | $14.13B | +1 | — |
| Q3 2025 | 20 | -1 | 49.48M | $6.35B | — | −1 |
| Q2 2025 | 18 | 0 | 41.97M | $5.08B | +2 | −2 |
| Q1 2025 | 16 | +1 | 41.02M | $4.58B | +1 | — |
| Q4 2024 | 15 | +1 | 35.01M | $3.41B | +1 | — |
| Q3 2024 | 13 | 0 | 33.66M | $3.89B | — | — |
| Q2 2024 | 13 | — | 33.92M | $3.61B | — | — |
Chi lo detiene · Q3 2025
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 10.59M | -0.6% | $1.36B | 0.7% | ▼ Trim | 6 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 9.34M | -10.2% | $1.20B | 0.9% | ▼ Trim | 6 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 7.73M | — | $991.15M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 7.24M | +1.7% | $928.38M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 2.95M | — | $378.26M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Goldman Sachs Group ✦ | 2.95M | — | $378.26M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Goldman Sachs Group ✦ | 2.95M | — | $378.26M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passivo) | 2.53M | +9.0% | $324.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passivo) | 2.53M | +9.0% | $324.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passivo) | 2.53M | +9.0% | $324.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | BlackRock ✦ (passivo) | 2.53M | +9.0% | $324.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | BlackRock ✦ (passivo) | 2.53M | +9.0% | $324.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 1.88M | -18.3% | $240.81M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 1.60M | +3.8% | $205.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 1.60M | +3.8% | $205.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 1.60M | +3.8% | $205.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 1.60M | +3.8% | $205.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (passivo) | 1.50M | -6.1% | $194.60M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.40M | -43.9% | $180.06M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Wellington Management ✦ | 1.40M | -43.9% | $180.06M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 1.40M | -43.9% | $180.06M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | Marshall Wace ✦ | 1.17M | -18.4% | $149.88M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 33 | Marshall Wace ✦ | 1.17M | -18.4% | $149.88M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | JPMorgan Chase ✦ | 1.08M | — | $137.87M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Adage Capital Partners ✦ | 210.19K | +1351.5% | $26.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 57 | AQR Capital Management ✦ | 135.96K | +85.0% | $17.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 58 | AQR Capital Management ✦ | 135.96K | +85.0% | $17.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 59 | AQR Capital Management ✦ | 135.96K | +85.0% | $17.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 60 | AQR Capital Management ✦ | 135.96K | +85.0% | $17.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 61 | Tweedy, Browne ✦ | 76.05K | -1.6% | $9.75M | 0.8% | ▼ Trim | 6 | SEC ↗ |
| 62 | Two Sigma Investments ✦ | 31.73K | -90.5% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 63 | Millennium Management ✦ | 9.97K | -98.8% | $1.28M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 64 | T. Rowe Price ✦ | 6.24K | -4.6% | $802,000 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 65 | T. Rowe Price ✦ | 6.24K | -4.6% | $802,000 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 66 | D. E. Shaw & Co. ✦ | 4.71K | -62.6% | $603,498 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 67 | D. E. Shaw & Co. ✦ | 4.71K | -62.6% | $603,498 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 68 | Gotham Asset Management ✦ | 1.96K | +10.8% | $250,837 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| Nessun nuovo acquirente tracciato questo trimestre. |
Uscito
| Point72 Asset Management | $90.36M | era 0.2% |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 2 detentori, 1.31M azioni, $431.09M dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
Frequentemente co-detenuti
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Provenienza: Proprietà ricavata dalle posizioni in azioni ordinarie 13F analizzate (universo monitorato, set comparabili per le variazioni); righe insider dai Moduli 3/4/5; partecipazioni dagli Schedule 13D/13G; ogni filing rimanda all'originale su SEC EDGAR.
Periodo di rendicontazione: Q3 2025 ·
Metodologia ·
Ottieni questo tramite l'API